GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab

被引:0
作者
P. Hadji
I. Kyvernitakis
P. H. Kann
C. Niedhart
L. C. Hofbauer
H. Schwarz
A. A. Kurth
F. Thomasius
M. Schulte
M. Intorcia
E. Psachoulia
T. Schmid
机构
[1] Krankenhaus Nordwest,Department of Bone Oncology, Endocrinology, and Reproductive Medicine
[2] Gynecological Endocrinology and Reproductive Medicine,Department of Bone Oncology
[3] Philipps University of Marburg,Centre for Internal Medicine
[4] Gemeinschaftspraxis, Endocrinology & Diabetes
[5] TU Dresden Medical Center,Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine 3 and Center for Healthy Aging
[6] Facharztpraxis für Orthopädie und Physiotherapie,Department of Bone Oncology and Osteoporosis Center
[7] Themistocles Gluck Hospital,undefined
[8] Krankenhaus Nordwest,undefined
[9] Amgen (Europe) GmbH,undefined
[10] Amgen Europe,undefined
来源
Osteoporosis International | 2016年 / 27卷
关键词
Bisphosphonates; Compliance; Denosumab; Osteoporosis; Persistence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2967 / 2978
页数:11
相关论文
共 247 条
[61]  
Borgstrom F(undefined)undefined undefined undefined undefined-undefined
[62]  
Herings RM(undefined)undefined undefined undefined undefined-undefined
[63]  
Silverman SL(undefined)undefined undefined undefined undefined-undefined
[64]  
Lakatos P(undefined)undefined undefined undefined undefined-undefined
[65]  
Takacs I(undefined)undefined undefined undefined undefined-undefined
[66]  
Marton I(undefined)undefined undefined undefined undefined-undefined
[67]  
Toth E(undefined)undefined undefined undefined undefined-undefined
[68]  
Zoltan C(undefined)undefined undefined undefined undefined-undefined
[69]  
Lang Z(undefined)undefined undefined undefined undefined-undefined
[70]  
Psachoulia E(undefined)undefined undefined undefined undefined-undefined